Top 10 Pre-Market Gainers From Thursday

By: via Benzinga
Repros Therapeutics (NASDAQ: RPRX) was trading up 19.53% after reporting success of its Enclomiphene drug to treat secondary ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.